Merck & Co., Inc. (MRK)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:02AM EDT. Market open.
| Previous close | 130.12 |
| Open | 131.72 |
| Bid | 130.37 x 900 |
| Ask | 130.42 x 900 |
| Day's range | 129.85 - 130.92 |
| 52-week range | 99.14 - 133.10 |
| Volume | |
| Avg. volume | 8,403,666 |
| Market cap | 330.206B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 144.84 |
| EPS (TTM) | 0.90 |
| Earnings date | 30 July 2024 |
| Forward dividend & yield | 3.08 (2.37%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 141.02 |
Insider MonkeyMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.07, expectations were $1.94. Merck & Co., Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank […]
Business WireMerck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
RAHWAY, N.J., April 29, 2024--Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Simply Wall St.Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Merck & Co., Inc. ( NYSE:MRK ) just released its quarterly report and things are looking bullish. The company beat...
© 2024 Yahoo. All rights reserved.